Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Advanced Gastric Cancer

Explore clinical trials studying HER2-positive Advanced Gastric Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HER2-positive Advanced Gastric Cancer trial results

Active, not recruiting

A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

NCT05993234

Conditions
HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma
Locations
  • Ordensklinikum Linz GmbH Barmherzige Schwestern Linz, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Kepler Universitätsklinikum Wels, Austria
  • Landesklinikum Wiener Neustadt Wiener Neustadt, Austria
View all 39 locations
View Trial Details

Related conditions